4//SEC Filing
Hicks Derek 4
Accession 0000950170-24-002507
CIK 0001652130other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:46 PM ET
Size
4.8 KB
Accession
0000950170-24-002507
Insider Transaction Report
Form 4
Hicks Derek
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2024-01-03$29.46/sh−3,877$114,216→ 36,987 total
Footnotes (1)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1 and January 3, 2024, and does not represent a volitional trade by the Reporting Person.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001901282
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:46 PM ET
- Size
- 4.8 KB